Top Story
June 17, 2019
Read the
Perspective
from
Jeffrey R. Starke, MD
Approximately 1 million treatment courses of new tuberculosis medicines designed for easy administration in children have been ordered by 93 countries since they were first introduced in 2016, according to the nonprofit organization TB Alliance.
“Strategic investments in TB treatment for children have corrected a dire market failure and enabled the rapid, widespread introduction of child-friendly TB medicines around the world,” Mel Spigelman, MD, president and CEO of TB Alliance, told Infectious Diseases in Children.
FDA News
June 17, 2019
The FDA announced today the approval of liraglutide for treating children aged at least 10 years with type 2 diabetes. “The FDA encourages drugs to be made…
At Issue
Infectious Disease News, June 2019
Research has shown that an influenza pandemic is more likely to strike in the spring or summer than at the height of seasonal influenza season. But is there any way to…
Cover Story
Infectious Disease News, June 2019
Influenza seasons are often unpredictable in timing, severity and which virus will predominate. Influenza pandemics, caused by novel viruses, are always unpredictable…
In the Journals
June 17, 2019
Frequent nightmares were an independent risk factor of suicide attempt and nonsuicidal self-injury among teenagers in China, according to a longitudinal study published…